Ajay Madan Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

CRNX Quotes by TradingView

Ajay Madan is Chief Development Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 176,995 shares of CRNX, which is worth approximately $10 Million. The most recent transaction as insider was on Mar 01, 2022, when has been sold 9,000 shares (Common Stock) at a price of $19.88 per share, resulting in proceeds of $178,920. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 177K
0% 3M change
0% 12M change
Total Value Held $10 Million

Ajay Madan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2022
BUY
Open market or private sale
$178,920 $19.88 p/Share
9,000 Added 4.84%
176,995 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
13,950 Added 6.98%
185,995 Common Stock
Feb 07 2022
SELL
Open market or private sale
$239,118 $17.83 p/Share
13,411 Reduced 7.23%
172,045 Common Stock
Oct 28 2021
BUY
Exercise of conversion of derivative security
$77,660 $0.73 p/Share
106,383 Added 36.55%
184,671 Common Stock
AM

Ajay Madan

Chief Development Officer
San Diego, CA

Track Institutional and Insider Activities on CRNX

Follow Crinetics Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRNX